0.5mg

Antivar

Antivar Tab 0.5mg

Entecavir

Pharmedic Pharmaceuticals Industries (Pvt.) Ltd.

Drug Identity

Active Ingredient
Entecavir
Drug Class
Antivirals For Systemic Use
ATC Code
J05AF10
Status
Essential Medicine

How to Take It

Dosage information not available for this product.

Important Warnings

risk of HIV resistance in patients not receiving highly active antiretroviral therapy, lamivudine-resistant chronic hepatitis B
risk of entecavir resistance Patients (particularly obese women) with hepatomegaly, hepatitis, other risk factors of liver disease
risk of lactic acidosis, sometimes fatal
Discontinue if deterioration in liver function, hepaticsteatosis, progressive hepatomegaly or unexplained lacticacidosis
Co-infection with hepatitis C or D or HIV, elderly, renal impairment
monitor patients regularly for hepatitis B, biochemical, virological and serological markers to determine treatment duration, Cirrhosis
monitor closely for hepatic decompensation
Monitor patients closely for several months after stopping therapy for acute exacerbations of hepatitis

Side Effects

Diarrhoeadizzinessdyspepsiafatigueheadachenausearaised serum amylaseraised serum lipasesleep disturbancesvomitingalopeciarashthrombocytopeniain-somniaraised ALT

Drug Interactions

Drugs that reduce renal function or compete for active tubular secretion.

Pregnancy & Lactation

Pregnancy
Avoid, use only when no safer alternative exists for a serious problem
Lactation
Contraindicated

Price Intelligence

Rs 12,025.68
DRAP approved maximum price · per pack of 30 · approved 01 Jul, 2025
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 30Rs 12,025.68

Should you consider an alternative?

Other options containing Entecavir, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.